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ABSTRACT
Alzheimer’s disease (AD) is a major global health priority and providing an efficient way for early
diagnosis of people developing dementia is important. The Mini-Mental State Examination (MMSE,
total score = 30) and Test Your Memory (TYM, total score = 50) are widely used as screening tests
for cognitive function. In the present study 174 subjects including healthy people (CON group)
and those having Alzheimer’s disease (AD group) were introduced to MMSE and TYM cognitive
tests adjusted to Iranian population. Sensitivities and specificities with optimal cut-off scores, area
under curve (AUC), positive predictive value (PPV) and negative predictive value (NPV) were meas-
ured for both tests. The MMSE scores of the CON and AD groups were 23.77±0.327 and
10.88±0.762, respectively. The TYM scores were 44.32±0.389 and 14.37±1.368 in the CON and
AD participants, respectively. Findings in the MMSE test were: AUC = 0.962, optimal cut-off score =
18.5, sensitivity = 0.90 and specificity = 0.96. Values in the TYM test were: AUC = 0.991, optimal
cut-off score = 31, sensitivity = 0.90 and specificity = 1. We found no correlation between the cog-
nitive performance and age in the CON group but a positive correlation in the AD patients. On
the other hand, t-test analysis indicated that achievement of the test scores are significantly sex
dependent, with more scores attained by the females. Taken together, in regard to correct classifi-
cation rate (CCR); the TYM test seems to be more appropriate for cognitive screening in our study.
However, considering an analogous AUC, both tests are comparable and have high sensitivity and
specificity for discriminating between people with and without AD.
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Introduction
Cognitive problems are a feature of many neurological and
medical diseases including stroke, Parkinson’s disease, head
injury, and epilepsy (Brown, Pengas, Dawson, Brown, &
Clatworthy, 2009). According to the World Alzheimer
Report (‘2018 Alzheimer’s disease facts and figures’,
Alzheimer’s Association, 2018), 46.8 million people world-
wide have dementia, and this number is expected to
increase to 74.7 million by 2030. More than 35 million peo-
ple have AD with a deterioration of memory and other
cognitive domains that leads to death within 3 to 9 years
after diagnosis. Although AD is not necessarily the out-
come of aging; nevertheless, evidence shows the principal
risk factor for AD is age and the diagnosis of AD after
85 years of age exceed one in three. The incidence of the
disease doubles every 5 years after 65 years of age.
Patients with AD typically present with symptoms
caused by poor recall of recently learnt visual and verbal
materials so that clinical testing reveals episodic memory
deficits (Greene, Baddeley, & Hodges, 1996; Nestor,
Scheltens, & Hodges, 2004). Patients presenting with these
symptoms and signs are diagnosed as having amnesic mild
cognitive impairment (aMCI) if their problems are mild
(with intact functional abilities) (Albert et al., 2011) or
probable AD if they have problems which impact on their
lives ( McKhann et al., 2011). Many patients with aMCI pro-
gress to AD (Dubois & Albert, 2004).
Dementia affects each person differently and also has a
significant impact on families and caregivers (Connell,
Boise, Stuckey, Holmes, & Hudson, 2004). Early diagnosis of
cognitive impairment may increase the chance of a slower
progression of the disease (Leifer, 2003) and make target
interventions before the progressive disease is established
(Petersen et al., 2001). However, in milder cases, the diag-
nosis of AD is more difficult and may remain unclear after
initial assessment. There has been a growing clinical and
research interest in the early identification of people at risk
of developing dementia. Actually, early accurate diagnosis
of AD is a major global health priority (Petersen et al.,
2009). Recently, numerous studies have attempted to iden-
tify a prognostic predictor of AD by using artificial neural
networks (Mecocci et al., 2002), brain magnetic resonance
imaging (Kanetaka et al., 2008; Tanaka, Hanyu, Sakurai,
Takasaki, & Abe, 2003), single-photon emission computed
tomography (Hongo et al., 2008) and cognitive function
tests (Saumier et al., 2007). Although all of these are useful,
however, disadvantages such as technical dependence,
high costs, contrast-agent related allergies, potential
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exposure to radionuclide irradiation, requiring referral to
specialists and taking time have limited their clinical appli-
cation (Tsai et al., 2015).
A large number of cognitive screening instruments are
available for the assessment of patient complaints of poor
memory or cognitive impairment (Tate, 2010); however,
none of them meets the three critical requirements for
widespread use by a non-specialist that is, taking minimal
operator time to administer, testing a reasonable range of
cognitive functions and sensitive to mild AD (Brown et al.,
2009). Further, dementia screening tools should be brief,
easy to use and valid in different cultures and across eld-
erly with various educational backgrounds (Lorentz,
Scanlan, & Borson, 2002). Conclusively, there is a need for
simple, quick and sensitive cognitive tests that provide a
more efficient way of identifying people with dementia
(National Collaborating Centre for Mental Health, 2007).
A short standardized mental status examination is help-
ful for the assessment of cognitive function in subjects
with memory impairment (Folstein, Folstein, & McHugh,
1975). Short cognitive tests can be divided into three
groups: orientation-dominated questionnaires, highly
selective tests and multidomain tests. Multidomain tests
are the most useful in aiding diagnosis (Brown, 2015). So
far, over 40 brief cognitive tests have been developed and
tested to identify people with cognitive impairment (Ozer,
Young, Champ, & Burke, 2016).
The Mini-Mental State Examination (MMSE) has been the
standard short cognitive test for more than 40 years
(Folstein et al., 1975). It is a widely used psychometric test
to screen for cognitive impairment as well as to track
development of cognitive function over time (Molloy &
Standish, 1997). This test evaluates a broad range of cogni-
tive functions including orientation, recall, attention, calcu-
lation, language processing and constructional praxis. The
MMSE has been demonstrated in many studies as valid and
brief test that provides satisfactory screening of cognitive
deficits and determines their severity at the time of evalu-
ation (Mitchell, 2009; Tsoi, Chan, Hirai, Wong, &
Kwok, 2015).
However, the MMSE has some disadvantages, including
insensitivity to the earliest changes in highly educated indi-
viduals (O’Bryant et al., 2008) and a lack of ability to meas-
ure frontal/executive function. Another test designed to
detect AD is Test Your Memory (TYM) introduced by Brown
et al. (2009). The TYM, as a supervised, self-completed
questionnaire comprising ten cognitive tasks is reported to
be a valid and reliable screening test for the detection of
AD. This test is quick to use, tests various skills, and takes
minimal operator time to administer (Ozer, Noonan,
et al., 2016).
The MMSE and TYM tests serve as measuring tools of
progression or improvement of cognition in cognitive disor-
ders (Mitchell, 2009; Tsoi et al., 2015). The MMSE test was
originally made in English and were translated and scientific-
ally validated in other languages such as Arabic (Abd-Al-
Atty, Abou-Hashem, Abd Elaziz, Abd El Gawad, & El-Gazzar,
2012), Germanic (Milian et al., 2012), Spanish (Steis &
Schrauf, 2009), Tiwanian (Liu et al., 1994), Czech (Bartos &
Raisova, 2016) and Chinese (Tsai et al., 2015) languages. Also
the TYM test is currently being translated into several differ-
ent languages such as Japanese (Hanyu et al., 2011),
Spanish (Ferrero-Arias & Turrion-Rojo, 2016), Hungarian
(Kolozsvari et al., 2017), Turkish (Mavis¸ et al., 2015), French
(Postel-Vinay et al., 2014), Polish (Szczesniak, Wojtynska, &
Rymaszewska, 2013) and Chinese (Li et al., 2018) languages.
The aim of the present study was to evaluate the effect-
iveness of the adapted MMSE and TYM tests for identifying
elderly Iranian population with AD. We also determined the
sensitivity and specificity for different cut-offs of the MMSE
and TYM tests in predicting the clinical diagnosis
of dementia.
Methods
Subject selection
All participants were recruited between May 2017 and
February 2018. They passed a physical examination and
completed forms of the MMSE and TYM tests. Participants
with AD (AD group) enrolled in this study were the
patients (65–90 years old) residing at the Welfare
Organizations including Emam Ali (A private center in
Tehran, Capital of Iran), and Golabchi (Kashan, Iran),
Barekat (Aran-Bidgol, Iran) and Miad (Ravand, Iran), the 3
cities located in the center of Iran. All Welfare
Organizations offer cares for aged people long life.
Informed consent was obtained for experimentation from
all participants. The diagnosis of AD was based on the cri-
teria of the National Institute of Neurological and
Communicative Disorders and Stroke and Alzheimer’s
Disease and Related Disorders Association (NINCDS-ADRDA)
(McKhann et al., 1984). The history of care health records
of the patients was screened and the participants who met
the criteria for AD with a stable clinical condition and com-
plete clinical evaluation were considered eligible for this
study. The other inclusion criteria were absence of subject-
ive cognitive complaints and no history of major
head trauma.
The normal control group (CON group) consisted of eld-
erly subjects were also examined by the specialist to con-
firm they are without any history or symptoms of
neurologic or psychiatric diseases. Controls were recruited
from random selection of elderly people in mosques, parks,
the relatives of the students and the nurses in the health
care centers.
The total sample comprised 174 participants distributed
between the two groups: the AD group with 60 patients
and the CON group with 114 cognitively healthy people.
This research was carried out in accordance with The Code
of Ethics of the World Medical Association (Declaration of
Helsinki). Also the study was approved ethically by Ethical
Committee of Kashan University of Medical Sciences. The
participants were only introduced to the two cognitive
tests and, hence, no intervention was performed. Figure 1
explains flow of AD and CON subjects selection enrolled in
the study.
The MMSE and TYM tests
The original MMSE comprises 5 tasks (and scores) including
orientation (10 scores), registration (3 scores), attention and
calculation (5 scores), recall (3 scores) and language (9
scores). The total score is 30. The TYM includes a series of
2 M. SALAMI ET AL.
10 tasks (and scores) consists of: orientation (10 scores),
ability to copy a sentence (2 scores), semantic knowledge
(3 scores), calculation (4 scores), verbal fluency (4 scores),
similarities (4 scores), naming (5 scores), visuospatial abil-
ities (7 scores) and recall of a copied sentence (6 scores).
The ability to do the test is also scored (5 scores) giving a
possible total of 50 scores.
The adapted versions of MMSE and TYM
Minor modifications were applied to some questions in the
MMSE and TYM tests based on a translation of the original
English-language version into Farsi (Iranian language). In
the fifth question of the MMSE test the word ‘world’ was
substituted by ‘rainy’; because it is difficult to pronounce
two consecutive consonant letters in Farsi language. The
two questions in the semantic knowledge section of the
TYM were substituted by questions familiar to Iranian peo-
ple. In the first question the subjects were asked to name
the Iranian president rather than the UK prime minister.
Also the second question of semantic knowledge ‘In what
year did the 1st World War start?’ uncommon knowledge
in Iran, was changed to ‘In what year did the war between
Iran and Iraq?’. The war was occurred between 1980 and
1988. Also we replaced the letter ‘W’ in the original version
of TYM with the letter ‘د’ in Farsi alphabet. Trained research
assistants who were blinded to each other’s assessments
administered the MMSE and TYM tests.
Validity of sensitivity and specificity of the tests
The area under curve (AUC) was reported based on
receiver operating characteristic (ROC) analysis. The test
cut-offs were determined empirically by examining optimal
combination of sensitivity and specificity at all cut-off val-
ues with the optimal cut-off being defined by maximal test
accuracy for diagnosis. Positive (PPV) and negative predict-
ive values (NPV) with 95% confidence intervals were
assessed at each of the cut-off point levels.
Data analysis
Since data were normally distributed, the comparisons
between the AD and CON groups and between the males
and females were made using unpaired t-test. Difference in
gender proportion between the two groups was analyzed
using the X2 test. Pearson’s correlation coefficient analysis
was applied to evaluate probable correlation between the
test scores with age. ROC curve analysis was applied to
assess the ability of the MMSE and TYM global and subtest
scores to discriminate between the AD and CON groups for
a range of cut-off values. The analyses assumed an alpha
risk of 0.05 in a bilateral contrast. Estimates are provided
with their 95% confidence intervals. Statistical analyses
were carried out using SPSS 16, Excel 2016 and Instat3.
Descriptive statistics were presented as means ± standard
error (SEM).
Results
Demographic data
The age of the participants ranged between 55 and
98 years; between 65 and 81 years in the CON subjects, and
between 55 and 98 years in the patients with AD. The AD
participants were significantly older than the CON people
where the mean age was 80.07 ± 0.62 and 68.24 ± 0.45 years
in the AD and CON groups, respectively (P< 0.0001). In the
CON group 66 (58%) and 48 (42%) people were men and
women, respectively. The AD group contained 20 (33%)
men and 40 (67%) women. Totally, the sample (n¼ 174)
included more percentage of female (61.9%) than males
(38.1%) (P< 0.002). Table 1 displays the baseline demo-
graphic characteristics.
Neuropsychological characteristics
Neuropsychological evaluations confirmed 60 (34.48%) peo-
ple with AD. The remaining 114 (65.52%) people were des-
ignated as controls and formed the reference group for the
subsequent analyses. The TYM score of the participants
assigned as normal people was 44.32 ± 0.389. Score of the
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Figure 1. Summary of patient flow.
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people proposed to have AD was 14.37 ± 1.368. According
the MMSE test the scores were 23.77 ± 0.327 and
10.88 ± 0.762 in the CON and AD patients, respectively.
The MMSE test
Sensitivities and specificities for diagnosis of AD with opti-
mal cut-off scores for the MMSE test are shown in Table 2.
All tasks showed a significant difference between the CON
and AD subjects. According to the MMSE test the AUC was
0.962 and a score of 18.5 was determined as optimal cut-
off to differentiate between the control people and AD
patients. At this cut-off the sensitivity and specificity were
0.90 and 0.96, respectively. The PPV value was found as
0.91 that means 91% of AD patients diagnosed correctly.
Also based on the NPV index 95% of normal people diag-
nosed correctly. Six out of 60 and 5 out of 114 were diag-
nosed incorrectly in the AD and control groups,
respectively.
Regarding the MMSE sub-scores the ‘orientation’ index
showed the highest concurrent sensitivity (0.95) and speci-
ficity (0.96) as well as a maximum AUC (0.984). Therefore,
considering the ‘orientation’ index the MMSE test resem-
bles the TYM test. It should be pointed out that this index
includes the same questions and sub-scores in both TYM
and MMSE cognitive tests. Also the ‘language’ gained the
second order in AUC (0.854). On the other hand, the
‘registration’ index displayed the lowest concurrent sensi-
tivity (0.57) and specificity (0.88) with an AUC of 0.742. The
‘recall’ subtest (AUC = 0.770) also showed to be a weak
index for assessment.
The TYM test
Sensitivities and specificities for diagnosis of AD with opti-
mal cut-off scores, and PPV and NPV for the TYM test are
shown in Table 3. All tasks showed a significant difference
between the CON and AD subjects. The AUC was 0.991
based on the TYM cognitive test, and a score of 31 pro-
vided the optimal cut-off for discriminating between the
CON and AD participants. At this cut-off the sensitivity and
specificity were 0.9 and 1, respectively. In this test the PPV
was 1 indicating that, according to TYM test, all AD
patients diagnosed correctly. Some (6 out of 60) of the par-
ticipants who assigned as AD people were scored as
normal. On the other hand, the NPV index showed a value
of 0.95 indicating that 95% of normal people diag-
nosed correctly.
Considering the TYM sub-scores the ‘orientation’ index
was found to have the highest concurrent sensitivity (0.95)
and specificity (0.96) with an AUC of 0.984. Also the
‘anterograde’ (AUC = 0.951) and ‘semantic knowledge’
(AUC = 0.949) displayed high sensitivity and specificity. On
the other hand, the ‘similarities’ index showed the lowest
concurrent sensitivity (0.67) and specificity (0.88) with an
AUC of 0.798. The other weak indices were ‘fluency’ (AUC =
0.891), ‘calculation’ (AUC = 0.890) and ‘copying’ (AUC
= 0.863).
Comparison of the MMSE and TYM results
Sensitivity and specificity of the MMSE and TYM tests com-
pared to clinical diagnosis of dementia (NINCDS-ADRDA cri-
teria) are presented in the Table 4.
The ROC curves (Figure 2) illustrate combined scores to
compare the ability of the MMSE and TYM tests for distin-
guishing the normal people and those with Alzheimer’s dis-
ease. The ROC analysis demonstrated that the AUC was
0.991 and 0.962 measured by the TYM and MMSE tests,
respectively. Whereas the MMSE test indicated a gap of
about 13 scores between the CON and AD subjects, the
TYM score gap was about 30 between the two groups. It
means that the gap percentage was 43.3% and 60%in the
MMSE and TYM tests, respectively.
The difference between the CON and AD subjects based
on the MMSE and TYM cognitive tests is shown in Figure
3a and b, respectively. In the MMSE test there is a clear
separation of most individuals; only the normal people
scored 23 and only the patients with AD scored 9. On
the other hand, performance of the TYM test made a fur-
ther separation between the CON and AD groups where
the former scored 43 and the latter scored 10.
Relevancy of the test scores with age
We assessed probable correlation between the scores of
both tests with age. Pearson’s analysis indicated no correl-
ation between age with the MMSE and TYM scores in the
CON group. Concerning the AD group, a positive Pearson’s
correlation coefficient was evident between age and the
Table 1. Demographic characteristics of the control (CON) and Alzheimer’s disease (AD) groups.
Age Sex
Mean of age (years) Range of age (years) Male (No/%) Female (No/%)
CON (114) 68.24 ± 0.45 65–81 66 (58%) 48 (42%)
AD (60) 80.07 ± 0.62 55–98 20 (33%) 40 (67%)
Total ( 174) 72.32 ± 0.68 55–98 86 (49.4%) 88 (50.6)
Table 2. Comparison of total Mini-Mental State Examination (MMSE) scores and subscores among the control (CON) and Alzheimer’s disease (AD) groups.
MMSE test CON group AD group Difference P value Cut-off Sen Spe PPV NPV AUC
Orientation (10) 9.74 ± 0.051 3.25 ± 0.365 6.487 ± 0.368 0.0001 8.5 0.95 0.96 0.93 0.97 0.984
Registration (3) 2.87 ± 0. 034 1.85 ± 0.157 1.018 ± 0.161 0.0001 2.5 0.57 0.88 0.71 0.80 0.742
Attention and calculation (5) 2.19 ± 0.200 0.32 ± 0.129 1.876 ± 0.238 0.0001 0.5 0.88 0.63 0.56 0.91 0.768
Recall (3) 1.46 ± 0.085 0.55 ± 0.117 0.906 ± 0.144 0.0001 0.5 0.67 0.86 0.71 0.83 0.770
Language (9) 7.51 ± 0.128 5.02 ± 0.244 2.492 ± 0.250 0.0001 5.50 0.73 0.92 0.83 0.87 0.854
Total (30) 23.77 ± 0.327 10.88 ± 0.762 12.889 ± 0.829 0.0001 18.5 0.90 0.96 0.91 0.95 0.962
Note. Sen, sensitivity; Spe, specificity; PPV, positive predictive value; NPV, negative predictive value; AUC, area under curve.
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MMSE (R¼ 0.42, P 0.001) and TYM (R¼ 0.492,
P 0.001) scores.
Sex dependency of the test scores
To evaluate if how the males and females respond the cog-
nitive tests the scores achieved by the two groups were
also analyzed by t-test. The statistical analysis indicated
that, in the two groups, the females outperformed the
males in both MMSE and TYM tests (P 0.001). The MMSE
scores attained by the CON males and females were
22.24 ± 0.407 and 25.88 ± 0.383, respectively. In AD patients
the values were 5.45 ± 0.569 and 13.6 ± 0.819 in the males
and females, respectively. Also, in the TYM test the CON
males and females scored 41.88 ± 0.47 and 47.67 ± 0.172,
respectively. In the AD patients the males and females
achieved scores of 4.45 ± 0.285 and 19.33 ± 1.529,
respectively.
Discussion
Using the adapted versions of two widespread cognitive
tests MMSE and TYM we attempted to determine the abil-
ity of each of them in both diagnosis of AD and making
separation between cognitive characteristics of the normal
and AD people. Analyzing data reflected in the AUC screen-
ing curves (Figure 2) and distribution of scores (Figure 3)
indicated that both cognitive tests are confident to apply
on the elderly population in several areas of Iran. The
scores in the original version of the MMSE test are: 27–30,
as normal; 21–26 as mild, 11–20 as moderate and 0-10 as
severe. However, the most widely used cut-off to suggest
dementia is score of 24 (Albanna et al., 2017). The cut-off
score obtained in our study for diagnosis of AD was 18.5.
Although the MMSE test assesses several different cogni-
tive domains and especially is useful for evaluation of
orientation, however, it includes only a single point for
visuospatial tasks and is ease to its memory, language, and
visuospatial tasks (Galasko et al., 1990; O’Bryant et al.,
2008). These disadvantages lead to the main problem in
that it is insensitive in the diagnosis of mild AD (Galasko
et al., 1990; Mathuranath, Nestor, Berrios, Rakowicz, &
Hodges, 2000; O’Bryant et al., 2008; Tombaugh & McIntyre,
1992). Brown et al believe that despite much strength the
MMSE test is only valuable in the assessment of patients
with recognized dementia, and, it fails testing a wide range
of cognitive tasks and sensitivity to mild AD (Brown et al.,
2009). Furthermore, previous studies indicate that MMSE
scores may be influenced by age, education level, cultural
background, social class, literacy and language (Freidl et al.,
Table 3. Comparison of total Test Your Memory (TYM) scores and subscores among the control (CON) and Alzheimer’s disease (AD) groups.
TYM test CON group AD group Difference P value Cutoff Sen Spe PPV NPV AUC
Orientation (10) 9.74 ± 0.051 3.25 ± 0.365 6.487 ± 0.368 0.0001 8.5 0.95 0.96 0.93 0.97 0.984
Copying (2) 1.75 ± 0.044 0.52 ± 0.102 1.238 ± 0.111 0.0001 0.50 0.67 0.98 0.95 0.85 0.863
Semantic knowledge (3) 2.41 ± 0.074 0.30 ± 0.096 2.112 ± 0.121 0.0001 0.50 0.82 1 1 0.91 0.949
Calculation (4) 3.18 ± 0.116 0.77 ± 0.151 2.409 ± 0.194 0.0001 2.50 0.90 0.76 0.67 0.93 0.890
Fluency (4) 3.73 ± 0.074 0.95 ± 0.189 2.778 ± 0.203 0.0001 2.50 0.81 0.96 0.92 0.91 0.891
Similarities (4) 3.75 ± 0.070 1.77 ± 0.232 1.979 ± 0.243 0.0001 3.50 0.67 0.88 0.75 0.83 0.798
Naming (5) 4.91 ± 0.049 1.92 ± 0.248 2.996 ± 0.253 0.0001 4.50 0.82 0.96 0.91 0.91 0.897
Visuospatial 1 (3) 2.77 ± 0.058 0.48 ± 0.133 2.289 ± 0.146 0.0001 1.50 0.83 0.95 0.89 0.91 0.916
Visuospatial 2 (4) 3.91 ± 0.036 1.08 ± 0.188 2.829 ± 0.191 0.0001 3.50 0.88 0.95 0.90 0.95 0.933
Anterograde (6) 3.71 ± 0.140 0.50 ± 0.118 3.211 ± 0.183 0.0001 1.50 0.87 0.92 0.85 0.93 0.951
Executive (help) (5) 4.49 ± 0.083 2.92 ± 0.064 1.575 ± 0.105 0.0001 3.50 0.95 0.84 0.76 0.97 0.904
Total (50) 44.32 ± 0.389 14.37 ± 1.368 29.949 ± 1.422 0.0001 31 0.90 1 1 0.95 0.991
Note. Sen, sensitivity; Spe, specificity; PPV, positive predictive value; NPV, negative predictive value; AUC, area under curve.
Table 4. Comparison of sensitivity and specificity of the Mini-Mental State Examination (MMSE) and Test Your Memory (TYM) tests between the control
(CON) and Alzheimer’s disease (AD) participants.
Test
Gold state (NINCDS-
ADRDA criteria for
diagnosis of AD)
Cut-off Sen Spe PPV NPV AUC CCR P ValuePositive Negative
TYM Positive 54 0 31 0.90 1 1 0.95 0.991 96.5 0.0001
Negative 6 114
MMSE Positive 54 5 18.5 0.90 0.96 0.91 0.95 0.962 93.6 0.0001
Note. Sen, sensitivity; Spe, specificity; PPV, positive predictive value; NPV, negative predictive value; AUC, area under curve; CCR, correct classification rate.
Figure 2. Receiver operating characteristic (ROC) curves screening for
Alzheimer’s disease. The curves show the relationship between probability of
a hit (true positive) and a false alarm (false positive) for the Mini-Mental
State Examination (MMSE) and Test Your Memory (TYM) scales in the healthy
controls (CON group, n¼ 114) and the patients with Alzheimer’s disease (AD
group, n¼ 60).
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1996; Jorm, Scott, Henderson, & Kay, 1988; Liu et al., 1994;
Lopez, Charter, Mostafavi, Nibut, & Smith, 2005). In the
Japanese version of MMSE Sakuma et al. gained an average
score of 28 in most of people with average education level
of 12.6 ± 2.9 years (Sakuma et al., 2017). In Czech version of
MMSE gained an average score of 28 ± 2 in the people
with average education level of 14 ± 3 years (Bartos &
Raisova, 2016). Since the people enrolled in our study were
either uneducated or with a very low education, therefore,
the cut-off score of 18.5 for diagnosis of AD in our study
can be expectable.
On the other hand, the TYM is psychometrically robust
and broad in its coverage of cognitive domains, leading to
less bias. This cognitive test is a supervised, self-completed
questionnaire comprising cognitive tasks. In addition to
memory and orientation tasks, the TYM also includes calcu-
lation, fluency, similarities, naming, and visuospatial tasks.
Moreover, it is believed that the TYM is more sensitive
than the MMSE in screening for non-Alzheimer’s dementias
(Brown et al., 2009). It is reported that although the TYM
compares favorably with the MMSE as a screening test for
cognitive impairment, however, the TYM display a higher
internal consistency and easily self-administration (van
Schalkwyk, Botha, & Seedat, 2012). This test has been used
in several countries and in many translated versions with
good results (Abd-Al-Atty et al., 2012; Hancock & Larner,
2011; Hanyu et al., 2011; Kolozsvari et al., 2017; Mavis¸
et al., 2015; Ojeda, Salazar, Due~nas, & Failde, 2012). The
scores introduced by developer of the TYM test are: 47–50,
as normal; 33–47 as mild AD, 25–33 as moderate AD and
<25 as severe AD. The cut-off for AD in our study was 31.
As reported by the developers of TYM we found that TYM
has a very high sensitivity and specificity for discriminating
between people with and without mild AD (Brown
et al., 2009).
Concerning education level, the AD people in our study
(at 8th and 9th decade of life) were either illiterate or with
a very low literacy that behaved the same in responding to
the tests.
We found no correlation between the cognitive per-
formances and age in the CON group but a positive correl-
ation in the AD patients. These results could be expectable;
comparable cognitive behavior in the younger normal peo-
ple compared to different cognitive function in the older
AD patients (Table 1). On the other hand, the test scores
gained by both groups were sex dependent, with more
scores attained by the females. In two recently clinical pub-
lished papers we also found that the TYM and MMSE tests
are sensitive to age (Agahi et al., 2018; Akbari et al., 2016).
Evidence from other versions of TYM test also indicates
that this test is not so powerful cognitive screening test in
uneducated or lower level educated individuals (Ferrero-
Arias & Turrion-Rojo, 2016). Using Chinese version of TYM
Li et al. reported a correlation between years of education
and scores of TYM test in MCI people but not AD or nor-
mal control groups (Li et al., 2018). French version of TYM
showed no effect of educational level, sex, or mood but a
significant effect of age (Postel-Vinay et al., 2014). In a
study on Polish people Szczesniak et al. suggested that the
age and the level of education of the respondents should
be considered when using the TYM test (Szczesniak
et al., 2013).
Strengths and limitations of the study
Here, we proved that both cognitive tests are reasonably
applicable in Iran’s society. However, this work had some
limitations. First, both the MMSE and TYM performance
may be influenced by educational level. We did not evalu-
ate the effect of education. Second, the subjects with prob-
lems in reading or writing, impaired visual acuity and
severe AD, are unable to complete the test.
Conclusion
Overall, in regard to correct classification rate (CCR), the
TYM test seems to be more appropriate for cognitive
screening in our study. However, considering an analogous
AUC, both tests are comparable and have high sensitivity
and specificity for discriminating between people with and
without AD. Our results and findings by others indicate
that the TYM test is a cognitive tool which may be superior
to some other neuropsychological tests such as the MMSE
Figure 3. Box plot showing the distribution of (a) the Mini-Mental State Examination (MMSE) and (b) Test Your Memory (TYM) scores among the control
(CON) and Alzheimer’s disease (AD) groups.
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for diagnosis of the AD patients from the healthy people.
Nevertheless, studies in different countries indicate that,
based on the population, some demographic characteristics
of the respondents must be considered when using the
TYM test. Also, some domains need to be further investi-
gated, including prospective validity and sensitivity to
change, expediency for different populations, clinical set-
tings and vulnerability to cultural and educational bias
(Ferrero-Arias & Turrion-Rojo, 2016).
Taken together, it seems that there is no still a univer-
sally valid cognitive screening test and regarding the target
population every clinic can use the best matching test.
However, despite a discrepancy between the two tests con-
sidering the total scores and the number and kind of tasks,
however, both tests include some common cognitive
domains and both shows acceptable concurrent validity.
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